Lindane
NDC Package 61748-400-02
Package Information
Lindane is shampoo is indicated for the treatment of head lice (infestations of Pediculosis humanis capitis), crab lice (infestations of Pthirus pubis), and their ova only in patients whocannot tolerate other approved therapies, orhave failed treatment with other approved therapies.Lindane Shampoo should be used in the context of an overall lice management program that includes:Visual inspection to ensure that the patient is currently infested with live lice (empty egg casings or "nits" can remain on hair shaft long after true infestation).Manual removal of nits using a comb designed for this purpose and/or individual removal with tweezers followed by close examination of the hair and scalp.Evaluation and treatment of sexual contacts simultaneously. Marketed by Versapharm Incorporated, this product is identified by NDC 61748-400 and is authorized under FDA application ANDA087266.
Identification & Billing
- RxCUI: 197878 - lindane 1 % Medicated Shampoo
- RxCUI: 197878 - lindane 10 MG/ML Medicated Shampoo
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 61748 - Versapharm Incorporated
- 61748-400 - Lindane
- 61748-400-02 - 1 BOTTLE, GLASS in 1 CARTON / 60 mL in 1 BOTTLE, GLASS
- 61748-400 - Lindane
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 61748-400-02 identifies a specific commercial package of 1 bottle, glass in 1 carton / 60 ml in 1 bottle, glass of Lindane, labeled by Versapharm Incorporated. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Versapharm Incorporated on November 21, 2011. The current certification is valid through December 31, 2017.
How is this Versapharm Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 61748040002. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.